Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 17/6/2019
SIETES contiene 92758 citas

 
 
 1 a 20 de 81 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Bekkering GE, Agoritsas T, Lytvyn L, Heen AF, Feller M, Moutzouri E, Abdulazeem H, Aertgeerts B, Beecher D, Brito JP, Farhoumand PD, Ospina NS, Rodondi N, van Driel M, Wallace E, Snel M, Okwen PM, Siemieniuk R, Vandvik PO, Kuijpers T, Vermandere M. Thyroid hormones treatment for subclinical hypothyroidism: a clinical practice guideline. BMJ 2019;365:14 de mayo. [Ref.ID 103122]
2.Enlace a cita original Cita con resumen
Vedal TSJ, Steen NE, Birkeland KI, Dieset I, Reponen EJ, Laskemoen JF, Rodevand L, Melle I, Andreassen OA, Molden E, Jönsson EG. Free thyroxine and thyroid-stimulating hormone in severe mental disorders: A naturalistic study with focus on antipsychotic medication. J Psychiatr Res 2018:25 de septiembre. [Ref.ID 102832]
3. Cita con resumen
Maier L, Pruteanu M, Kuhn M, Zeller G, Telzerow A, Anderson EE, Brochado AR, Fernandez KC, Dose H, Mori H, Patil KR, Bork P, Typas A. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 2018;555:29 de marzo. [Ref.ID 102577]
4. Cita con resumen
Anónimo. Transport d'anions ou de cations organiques et interactions. Prescrire 2012;32:676-7. [Ref.ID 93662]
5.Tiene citas relacionadas Cita con resumen
Razvi S, Weaver JU, Butler TJ, Pearce SHS. Levothyroxine treatment of subclinical hypothyroidism, fatal and nonfatal cardiovascular events, and mortality. Arch Intern Med 2012;172:811-23. [Ref.ID 93055]
6.Tiene citas relacionadas Cita con resumen
Collet T-H, Gussekloo J, Bauer DC, den Elzen WPJ, Cappola AR, Balmer P, Iervasi G, Asvold BO, Sgarbi JA, Völzke H, Gencer B, Maciel RMB, Molinaro S, Bremner A, Luben RN, Maisonneuve P, Comuz J, Newman AB, Khaw K-T, Westendorp RGJ, Franklyn JA, Vittinghoff E, Walsh JP, Rodondi N, for the Thyroid Studies Collaboration. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med 2012;172:799-809. [Ref.ID 93054]
7.
Bell CM, Brener SS, Gunraj N, Huo C, Bierman AS, Scales DC, Bajcar J, Zwarenstein M. Association of ICU or hospital admission with unintentional discontinuation of medications for chronic diseases . JAMA 2011;306:840-7. [Ref.ID 91011]
8.Tiene citas relacionadas Cita con resumen
Turner MR, Camacho X, Fischer HD, Austin PC, Anderson GM, Rochon PA, Lipscombe LL. Levothyroxine dose and risk of fractures in older adults: nested case-control study. BMJ 2011;342:1011. [Ref.ID 90792]
9.Tiene citas relacionadas
Leese GP, Flynn RV. Levothyroxine dose and fractures in older adults. BMJ 2011;342:986-7. [Ref.ID 90785]
10. Cita con resumen
Anónimo. Aumento del riesgo de fractura por medicamentos. Boletín Terapéutico Andaluz 2010;26:21-4. [Ref.ID 89893]
11. Cita con resumen
Bolk N, Viser TJ, Nijman J, Jongste IJ, Tijssen JGP, Berghout A. Effects of evening vs morning levothyroxine intake. A randomized double-blind crossover trial. Arch Intern Med 2010;170:1996-2003. [Ref.ID 89785]
12. Cita con resumen
Anónimo. Generic drugs revisited. Med Lett Drugs Ther 2009;51:81-2. [Ref.ID 87347]
13.
Centanni M, Gargano L, Canettieri G, Viceconti N, Franchi A, Fave GD, Annibale B. Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis. N Engl J Med 2006;354:1787-95. [Ref.ID 76784]
14.Tiene citas relacionadas Cita con resumen
Roos A, Linn-Raske SP, van Domburg RT, Tijssen JP, Berghout A. The starting dose of levothyroxine in primary hypothyroidism treatment. A prospective, randomized, double-blind trial. Arch Intern Med 2005;165:1714-20. [Ref.ID 74589]
15.Tiene citas relacionadas
Wartofsky L. Levothyroxine therapy for hypothyroidism. Should we abandon conservative dosage titration?. Arch Intern Med 2005;165:1683-4. [Ref.ID 74587]
16.
Escobar-Morreale HF, Botella-Carretero JI, Gómez-Bueno M, Galán JM, Barrios V, Sancho J. Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing l-thyroxine plus liothyronine with l-thyroxine alone. Ann Intern Med 2005;142:412-24. [Ref.ID 73359]
17.
Anselmo J, Cao D, Karrison T, Weiss RE, Refetoff S. Fetal loss associated with excess thyroid hormone exposure. JAMA 2004;292:691-5. [Ref.ID 71100]
18. Cita con resumen
Toft A, Beckett G. Use of recombinant thyrotropin. Lancet 2002;359:1874-5. [Ref.ID 62256]
19.
Briët JM, van Wassenaer AG, Dekker FW, de Vijlder JJM, van Baar A, Kok JH. Neonatal thyroxine supplementation in very preterm children: developmental outcome evaluated at early school age. Pediatrics 2001;107:712-8. [Ref.ID 56342]
20.
Bauer DC, Ettinger B, Nevitt M C, Stone KL, for the Study of Osteoporotic Fractures Research Group. Risk for fracture in women with low serum levels of thyroid-stimulating hormone. Ann Intern Med 2001;134:561-8. [Ref.ID 56017]
Seleccionar todas
 
 1 a 20 de 81 siguiente >>